SLC26A3 and viral infectious disease: We therefore selected PD-CLD-Fc as our lead compound since it inhibited viral infection most potently in vitro, had the longest half-life in hamsters, and was the only compound to reduce nasal turbinate and lung viral titer in a hamster model of SARS-CoV-2 infection.